Damian McNamara is a journalist for Medscape Medical News and MDedge. He worked full-time for MDedge as the Miami Bureau covering a dozen medical specialties during 2001-2012, then as a freelancer for Medscape and MDedge, before being hired on staff by Medscape in 2018. Now the two companies are one. He uses what he learned in school – Damian has a BS in chemistry and an MS in science, health and environmental reporting/journalism. He works out of a home office in Miami, with a 100-pound chocolate lab known to snore under his desk during work hours.
News
Three-strategy combo reduces pancreatoduodenectomy fistula risk
MIAMI BEACH – Three strategies were associated with a statistically significant drop in clinically relevant postoperative pancreatic fistula.
News
Proceed cautiously with liver cancer resection in elderly patients
Mortality rates were higher in patients 75 years and older undergoing hepatectomy for perihilar cholangiocarcinoma.
News
Debulking called reasonable for unresectable liver cancer
When advanced neuroendocrine liver cancer is unresectable, is debulking an appropriate option?
News
Neoadjuvant chemoradiation may give transplant the edge over resection in biliary cancer
MIAMI BEACH - The optimal surgical treatment of hilar cholangiocarcinoma is still controversial.
News
BRCA2 mutations linked to greater risk for pancreatic cancer
MIAMI BEACH – A higher incidence of pancreatic abnormalities on imaging among BRCA2 mutation carriers may provide a potential screening target.
News
A new form of photodynamic therapy remains controversial
Daylight PDT is catching on in Europe, but U.S. dermatologists have some concerns about this alternative approach.
Video
VIDEO: Sexuality, fertility are focus of cancer education website
MIAMI BEACH – Cancer patients may be reticent to discuss issues of sexuality and fertility related to their disease. At the same time, their...
Video
VIDEO: Genomics, other advances further highlight how breast cancer differs in men
MIAMI BEACH – Men’s version of breast cancer differs so significantly from women’s that it is unreasonable to extrapolate findings from one to the...
Video
VIDEO: Multiple PARP inhibitors show promise in breast cancer treatment
MIAMI BEACH – Driven by efficacy demonstrated in ovarian cancer, a number of PARP inhibitors are in development and hold promise for treatment of...
Video
VIDEO: Vaccines, combination therapy hold most promise for optimizing immunotherapy in breast cancer
MIAMI BEACH – Although typically not as immunogenic as melanoma or lung cancer, breast cancer can respond to immunotherapy.
Video
VIDEO: Future therapies look promising for HER2 treatment-resistant breast cancer patients
Several antibody-drug conjugates and additional types of agents are showing promise for HER2 treatment-resistant breast cancer.
News
Tips for taming atopic dermatitis and managing expectations
MIAMI – Even with recent FDA approval of the first new prescription agent to treat atopic dermatitis in more than 10 years, and more therapies...
News
No AR in CTCs linked with better survival in advanced prostate cancer
A new biomarker in CTCs significantly predicts a greater likelihood survival by stratifying people with metastatic castration-resistant prostate...
News
Laser resurfacing can effectively minimize post surgery scars
MIAMI – A technique that includes considerable downtime for patients can notably improve the appearance of scars after skin cancer surgery.
News
RNA-based biopsy test bests NCCN risk stratification for PC prognosis
ORLANDO – Can genomic testing at the diagnostic biopsy stage identify patients most likely to develop metastases from prostate cancer?